Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas(†)

The objective of this study was to evaluate whether longitudinal levels of serum YKL-40 correlate with disease status or survival in adults with gliomas. Patients with histologically confirmed gliomas were eligible for this longitudinal study. Serum samples were collected prospectively and concurren...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Iwamoto, Fabio M., Hottinger, Andreas F., Karimi, Sasan, Riedel, Elyn, Dantis, Jocelynn, Jahdi, Maryam, Panageas, Katherine S., Lassman, Andrew B., Abrey, Lauren E., Fleisher, Martin, DeAngelis, Lisa M., Holland, Eric C., Hormigo, Adília
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199155/
https://ncbi.nlm.nih.gov/pubmed/21831900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados